Skip to main content

Fate Therapeutics Inc

FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001434316

In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Fate Therapeutics Inc as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
158
+13 vs. Q4 2025
Shares held
74.1M
+10.9M (+17.3%) vs. Q4 2025
Total value
$88.9M
+$26.8M (+43.1%) vs. Q4 2025
New holders
28
56 more added
Sold out
15
32 more reduced

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FATE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 158 institutions
Q1 2021: 260 institutionsQ2 2021: 272 institutionsQ3 2021: 266 institutionsQ4 2021: 250 institutionsQ1 2022: 249 institutionsQ2 2022: 233 institutionsQ3 2022: 239 institutionsQ4 2022: 228 institutionsQ1 2023: 182 institutionsQ2 2023: 188 institutionsQ3 2023: 171 institutionsQ4 2023: 159 institutionsQ1 2024: 167 institutionsQ2 2024: 182 institutionsQ3 2024: 164 institutionsQ4 2024: 159 institutionsQ1 2025: 132 institutionsQ2 2025: 139 institutionsQ3 2025: 143 institutionsQ4 2025: 146 institutionsQ1 2026: 158 institutionsQ2 2026: 156 institutions
Value heldQ1 2026: $88.9M
Q1 2021: $7.73BQ2 2021: $8.20BQ3 2021: $5.67BQ4 2021: $5.66BQ1 2022: $3.92BQ2 2022: $2.70BQ3 2022: $2.41BQ4 2022: $1.07BQ1 2023: $641.6MQ2 2023: $519.6MQ3 2023: $202.9MQ4 2023: $357.2MQ1 2024: $904.0MQ2 2024: $401.1MQ3 2024: $401.6MQ4 2024: $166.5MQ1 2025: $76.3MQ2 2025: $88.9MQ3 2025: $101.6MQ4 2025: $70.9MQ1 2026: $88.9MQ2 2026: $193.2M
Institutions holding FATE and their total value by quarter
QuarterHoldersValue
Q2 2026156$193.2M
Q1 2026158$88.9M
Q4 2025146$70.9M
Q3 2025143$101.6M
Q2 2025139$88.9M
Q1 2025132$76.3M
Q4 2024159$166.5M
Q3 2024164$401.6M
Q2 2024182$401.1M
Q1 2024167$904.0M
Q4 2023159$357.2M
Q3 2023171$202.9M
Q2 2023188$519.6M
Q1 2023182$641.6M
Q4 2022228$1.07B
Q3 2022239$2.41B
Q2 2022233$2.70B
Q1 2022249$3.92B
Q4 2021250$5.66B
Q3 2021266$5.67B
Q2 2021272$8.20B
Q1 2021260$7.73B

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Fate Therapeutics Inc; share changes are against Q4 2025.

Institutions holding FATE in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Virtu Financial LLC76,561$92.0K0.00%+7,690+11.2%Added
Price T Rowe Associates Inc76,633$92.0K0.00%+22,163+40.7%Added
SG Americas Securities, LLC80,139$96.0K0.00%+41,226+105.9%Added
State of Tennessee, Treasury Department90,000$108.0K0.00%00.0%Unchanged
Deutsche Bank AG91,679$110.0K0.00%00.0%Unchanged
Los Angeles Capital Management LLC95,185$114.2K0.00%00.0%Unchanged
HSBC Holdings PLC97,684$116.2K0.00%00.0%Unchanged
Mariner, LLC98,295$117.9K0.00%+83,406+560.2%Added
Schulhoff & Co Inc100,000$120.0K0.05%+100,000New
Wells Fargo & Company100,975$121.2K0.00%−71,308−41.4%Reduced
Cerity Partners LLC113,544$136.3K0.00%+61,055+116.3%Added
Quadrature Capital Ltd120,343$144.4K0.00%−177,739−59.6%Reduced
National Philanthropic Trust125,000$150.0K0.00%00.0%Unchanged
Headlands Technologies LLC125,708$150.8K0.02%+125,708New
Rhumbline Advisers132,308$158.8K0.00%−14,453−9.8%Reduced
SEI Investments Co138,580$166.3K0.00%+70,937+104.9%Added
CWM, LLC139,796$167.8K0.00%+88,007+169.9%Added
LPL Financial LLC147,746$177.3K0.00%+2,930+2.0%Added
Alliancebernstein L.P.187,700$184.4K0.00%00.0%Unchanged
Bridgeway Capital Management, LLC185,000$222.0K0.00%+50,000+37.0%Added
Bank of America Corp188,564$226.3K0.00%+37,457+24.8%Added
Assenagon Asset Management S.A.190,252$228.3K0.00%+41,599+28.0%Added
Woodline Partners LP238,650$286.4K0.00%−118,000−33.1%Reduced
Susquehanna International Group, LLP298,496$358.2K0.00%−11,695−3.8%Reduced
Gsa Capital Partners LLP298,881$359.0K0.02%+85,236+39.9%Added
Bank of New York Mellon Corp306,987$368.4K0.00%−610−0.2%Reduced
Ieq Capital, LLC324,788$389.7K0.00%+203,287+167.3%Added
Nuveen, LLC339,073$406.9K0.00%+2,201+0.7%Added
Invesco Ltd.375,886$451.1K0.00%−3,139−0.8%Reduced
XTX Topco Ltd389,169$467.0K0.01%+24,431+6.7%Added
Privium Fund Management B.V.414,311$497.2K0.10%+45,211+12.2%Added
Man Group plc430,073$516.1K0.00%+168,901+64.7%Added
Connor, Clark & Lunn Investment Management Ltd.469,785$563.7K0.00%+358,558+322.4%Added
DAFNA Capital Management LLC550,000$660.0K0.15%00.0%Unchanged
Jane Street Group, LLC646,979$776.4K0.00%−195,828−23.2%Reduced
Vanguard Fiduciary Trust Co653,761$784.5K0.00%+653,761New
Charles Schwab Investment Management Inc756,273$907.5K0.00%−28,355−3.6%Reduced
Morgan Stanley767,748$921.3K0.00%−149,198−16.3%Reduced
Bruce & Co., Inc.789,188$947.0K0.27%+60,000+8.2%Added
Monaco Asset Management SAM810,000$972.0K0.31%−20,000−2.4%Reduced
Northern Trust Corp811,920$974.3K0.00%+79,250+10.8%Added
Irenic Capital Management LP878,055$1.05M0.10%+878,055New
Dimensional Fund Advisors LP883,790$1.06M0.00%−693,688−44.0%Reduced
Citadel Advisors LLC942,926$1.13M0.00%+193,590+25.8%Added
Tang Capital Management LLC1,167,773$1.40M0.07%00.0%Unchanged
Goldman Sachs Group Inc1,327,757$1.59M0.00%−107,283−7.5%Reduced
UBS Group AG1,821,715$2.19M0.00%+1,418,191+351.5%Added
State Street Corp2,263,173$2.72M0.00%−2,044−0.1%Reduced
Geode Capital Management, LLC2,590,429$3.11M0.00%+122,081+4.9%Added
Renaissance Technologies LLC2,974,683$3.57M0.01%+613,802+26.0%Added
AQR Capital Management LLC3,001,521$3.60M0.00%+1,839,516+158.3%Added
Johnson & Johnson3,379,064$4.05M0.62%00.0%Unchanged
Two Sigma Investments, LP3,466,786$4.16M0.00%+1,732,722+99.9%Added
Acadian Asset Management LLC4,120,200$4.94M0.01%+1,188,307+40.5%Added
Vanguard Portfolio Management LLC4,134,585$4.96M0.00%+4,134,585New
Vanguard Capital Management LLC4,192,063$5.03M0.00%+4,192,063New
BlackRock, Inc.10,068,614$12.1M0.00%−107,873−1.1%Reduced
Redmile Group, LLC12,872,946$15.4M1.02%00.0%Unchanged
Vestal Point Capital, LP0$00.00%−1,725,000−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−1,651,700−100.0%Sold out
Millennium Management LLC0$00.00%−522,617−100.0%Sold out
Knott David M Jr0$00.00%−365,000−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−192,682−100.0%Sold out
Shay Capital LLC0$00.00%−70,000−100.0%Sold out
Nine Masts Capital Ltd0$00.00%−19,445−100.0%Sold out
Tiaa Trust, National Association0$00.00%−17,592−100.0%Sold out
Sagewood Asset Management LP0$00.00%−15,003−100.0%Sold out
AlphaCore Capital LLC0$00.00%−12,689−100.0%Sold out
HBK Sorce Advisory LLC0$00.00%−10,659−100.0%Sold out
Amalgamated Bank0$00.00%−3,417−100.0%Sold out
Optiver Holding B.V.0$00.00%−1,132−100.0%Sold out
Clearstead Advisors, LLC0$00.00%−18−100.0%Sold out
Turning Point Benefit Group, Inc.0$00.00%−14−100.0%Sold out
Vanguard Group Inc––––Not filed